XOMA
XOMA Royalty Corporation
$40.17
+0.00%
2026-07-21
About XOMA Royalty Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. As of July 14, 2026, XOMA Royalty Corporation operates as a subsidiary of Ligand Pharmaceuticals Incorporated.
Key Fundamentals
P/E Ratio
25.59
Forward P/E
18.77
EPS (TTM)
$1.57
ROE
34.2%
Revenue Growth (YoY)
-22.6%
Profit Margin
69.6%
Debt/Equity
110.48
Price/Book
5.15
Beta
0.86
Market Cap
$710.2M
Avg Volume (10D)
764K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$45.22
60D Low
$37.00
Avg Volume
319K
Latest Close
$40.17
Get breakout alerts for XOMA
Sign up for Breakout Scanner to receive daily notifications when XOMA triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
XOMA Royalty Corporation (XOMA) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors XOMA daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. XOMA operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.